134 related articles for article (PubMed ID: 3279011)
1. Glucose, insulin and glucagon response to intravenous glucose load in patients on chronic hemodialysis.
Shasha SM; Nusem D; Kanter Y; Weiner F
Isr J Med Sci; 1988 Jan; 24(1):15-9. PubMed ID: 3279011
[TBL] [Abstract][Full Text] [Related]
2. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
[TBL] [Abstract][Full Text] [Related]
3. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
Alvestrand A; Mujagic M; Wajngot A; Efendic S
Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
[TBL] [Abstract][Full Text] [Related]
4. Serum reverse T3 assay for predicting glucose intolerance in uremic patients on dialysis therapy.
De Marchi S; Cecchin E; Villalta D; Tesio F
Clin Nephrol; 1987 Apr; 27(4):189-98. PubMed ID: 3581526
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Hyperglucagonemia of renal failure.
Bilbrey GL; Faloona GR; White MG; Knochel JP
J Clin Invest; 1974 Mar; 53(3):841-7. PubMed ID: 4812442
[TBL] [Abstract][Full Text] [Related]
7. Studies of carbohydrate metabolism after hemodialysis and hemofiltration in uremic patients.
Geronemus R; Bosch JP; Thornton J; Rayfield EJ
Arch Intern Med; 1982 Apr; 142(4):707-10. PubMed ID: 7041844
[TBL] [Abstract][Full Text] [Related]
8. [Aspects of carbohydrate metabolism in chronic uremic patients treated with periodic hemodialysis].
Redaelli B; Salvadeo A; Ponticelli C; Imbasciati E; Graziani G
Minerva Nefrol; 1967; 14(4):158-62. PubMed ID: 5607555
[No Abstract] [Full Text] [Related]
9. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
10. Effects of erythropoietin on glucose tolerance in hemodialysis patients.
Chagnac A; Weinstein T; Zevin D; Korzets A; Hirsh J; Gafter U; Levi J
Clin Nephrol; 1994 Dec; 42(6):398-400. PubMed ID: 7882604
[TBL] [Abstract][Full Text] [Related]
11. Effects of propranolol and hemodialysis on the response of glucose, insulin, C-peptide and cyclic AMP to glucagon challenge.
Pun KK; Yeung CK; Ho PW; Lin HJ; Chan MK; Yeung RT
Clin Nephrol; 1984 Apr; 21(4):235-40. PubMed ID: 6329569
[TBL] [Abstract][Full Text] [Related]
12. [Aspects of carbohydrate metabolism in chronic uremic patients treated with periodic hemodialysis: determination of phosphoremia during some dynamic tests].
Redaelli B; Salvadeo A; Imbasciati E; Ponticelli C
Arch Ital Urol Nefrol; 1967; 39(6):459-67. PubMed ID: 5606789
[No Abstract] [Full Text] [Related]
13. Assessment of tissue sensitivity to insulin in uraemic patients on long-term haemodialysis therapy.
Schmitz O; Hjøllund E; Alberti KG; Orskov H; Beck-Nielsen H
Diabetes Res; 1985 Mar; 2(2):57-63. PubMed ID: 4042532
[TBL] [Abstract][Full Text] [Related]
14. High circulating levels of glucagon and gastrin in anephric subjects.
Trimble ER; Buchanan KD
N Z Med J; 1976 May; 83(564):357-60. PubMed ID: 785321
[TBL] [Abstract][Full Text] [Related]
15. [Insulin resistance in the uremic patient: effects of hemodialysis].
Sechi LA; Melis A; Pala A; Orecchioni C; Tedde R
Boll Soc Ital Biol Sper; 1990 Oct; 66(10):993-9. PubMed ID: 2096883
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
Holst JJ; Burcharth F; Kühl C
Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
[TBL] [Abstract][Full Text] [Related]
17. Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure.
Fliser D; Rett K; Hübinger A; Ritz E
Nephrol Dial Transplant; 1995; 10(5):643-7. PubMed ID: 7566576
[TBL] [Abstract][Full Text] [Related]
18. [Radioimmunologic analysis of insulin (IRI) in glucose metabolism in uremic patients].
Martino F; Baviera G; Bonanno N; Purello D'Ambrosio F
Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):329-39. PubMed ID: 2701029
[TBL] [Abstract][Full Text] [Related]
19. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin release in response to glucose is impaired in chronic renal failure.
Franceschini R; Robaudo C; Corsini G; Cataldi A; Bruno E; Russo R; Rolandi E; Barreca T
Biomed Pharmacother; 1998; 52(5):208-13. PubMed ID: 9755817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
